Medigen Vaccine Biologics Corporation announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced operating loss was TWD 121.897 million compared to TWD 90.525 million a year ago. Net loss was TWD 126.183 million compared to TWD 92.887 million a year ago. Basic loss per share was TWD 0.81 compared to TWD 0.59 a year ago. For the nine months, sales was TWD 640,000 compared to TWD 0 a year ago. Operating loss was TWD 417.406 million compared to TWD 305.042 million a year ago. Net loss was TWD 427.151 million compared to TWD 312.916 million a year ago. Basic loss per share was TWD 2.74 compared to TWD 2.11 a year ago.